LCM
IRWD icon

Laurion Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Laurion Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,841
Closed -$110K – 449
2024
Q2 		$110K Buy
+16,841
New +$119K ﹤0.01% 511
2020
Q3 		– Sell
-40,514
Closed -$418K – 983
2020
Q2 		$418K Buy
+40,514
New +$415K ﹤0.01% 655
2019
Q2 		– Sell
-153,954
Closed -$1.75M – 1028
2019
Q1 		$1.75M Buy
+153,954
New +$1.72M 0.02% 398

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Laurion Capital Management's IRWD Position: Q3 2024 in Review

Laurion Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 16,841 shares — an estimated $110K sold.

Laurion Capital Management first reported a position in IRWD in Q1 2019 and held it in 3 quarters. The position peaked at $1.75M in Q1 2019. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Laurion Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 16,841 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $110K.
  • Laurion Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Laurion Capital Management's Ironwood Pharmaceuticals position peaked at $1.75M in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.